Attached files
| file | filename |
|---|---|
| EX-3.1 - EX-3.1 - Landos Biopharma, Inc. | d89081dex31.htm |
| S-1/A - S-1/A - Landos Biopharma, Inc. | d89081ds1a.htm |
| EX-5.1 - EX-5.1 - Landos Biopharma, Inc. | d89081dex51.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our reports dated June 30, 2020 (except for the fourth paragraph of Note 11, as to which the date is February 1, 2021), in Amendment No. 2 to the Registration Statement (Form S-1 No. 333-252083) and related Prospectus of Landos Biopharma, Inc. for the registration of its common stock.
/s/ Ernst & Young LLP
Raleigh, North Carolina
February 1, 2021